meRfi®-GM
Probiotics (living agents) & Hepatocellular Carcinoma (HCC)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
A Probiotics (living agents) yogurt containing Lactobacillus rhamnosus, Streptococcus thermophilus, and Wiessella cibaria also reduced Aflatoxin metabolites in the urine of children who ate aflatoxin B1-infected maize
Probiotics can help reduce the risk of [Hepatocellular Carcinoma (HCC)](bra…
References (Sources)
- Clinical Aspects of Gut Microbiota in Hepatocellular Carcinoma Management
- Epigenetic Regulation at the Interplay Between Gut Microbiota and Host Metabolism
- Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
- Microbiota, NASH, HCC and the potential role of probiotics
- Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
- Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4
- Reduction of Aflatoxin B1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food "Tofu".